A Survey of Medical Oncologist’s Opinions and Perceptions Regarding the Management of Dermatologic Toxicities among mCRC Patients Treated with Vectibix (20160258)First published 26/04/2017 Last updated 02/07/2024 EU PAS number: EUPAS18060StudyFinalised